Svar Life Science

Svar Life Science is a Malmö-based company operating at the intersection of diagnostics, contract research, and specialized assay development. It leverages its proprietary iLite® cell-based assay platform and deep expertise in the complement system to offer products and services for biopharma companies, particularly in advanced therapy and biologics development. The company's business model integrates product sales (kits and reagents) with high-value CRO and diagnostic testing services, creating multiple revenue streams. With over 30 years of heritage through its Wieslab diagnostic arm and ISO/GMP-certified facilities, Svar is positioned as a specialized partner for complex bioanalytical and regulatory challenges.

Proprietary iLite® cell-based assay platform using luciferase reporter gene readouts for functional bioassays (ADCC, ADCP, CDC, T-cell). Deep expertise and comprehensive product portfolio for complement system analysis. Specialized assays for AAV gene therapy immunogenicity.

Competes with large, diversified CROs (e.g., Charles River, LabCorp) and life science tool vendors (e.g., Thermo Fisher) offering similar testing services and kits. Also faces competition from niche specialty assay developers and diagnostic service labs. Differentiation is achieved through deep expertise in complement and cell-based functional assays, and an integrated product-service model.